Elbasvir/Grazoprevir fixed-dose combination
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Elbasvir/Grazoprevir fixed-dose combination, covering 2020-09-07 to 2020-09-07. Get the full timeline:
Most recent: Clinical Trial Update: Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe Fibrosis [Phase 3]